
Tiffany Sia MD
@tsialater
Followers
485
Following
2K
Media
24
Statuses
238
Bay Area ✈️ L.A ✈️ NYC | Current Memorial Sloan Kettering GYN Onc Fellow |❤️|🪴| 👩🏻🍳 | 🏔
New York, NY
Joined October 2009
Yesterday I presented my research thesis summarizing the work @YingLiu88 and I have done over the past 4 years on germline #genetictesting in #ovariancancer. It’s been a great research journey so far! . Thankful for great #mentors @TeamOvary_MSK @MSKCancerCenter @TeamEndo_MSK
1
2
17
RT @IGCSociety: Stigma and misconceptions surrounding #UterineCancer can impact women around the world. This Uterine Cancer Awareness Month….
0
8
0
Can’t believe 4 years of #gynoncology fellowship have gone by! Couldn’t have chosen a better group to do it with @AaronPraissMD @RyanKahnMD1 @FionanDonohoe @leitaomd @KaraLongRoche.
2
0
15
RT @YingLiu88: Great collaboration with #JohnChan @SutterHealth using @myriadgenetics registry data! Rates of germline mutations in uterine….
0
3
0
RT @mydocwire: 🚨 New research presented at #ASCO25 out of @MSKCancerCenter:.🧬 #Papsmear #ctDNA allows for earlier identification of #endome….
0
1
0
Go @saramoufarrij1 go!!!!!.
So proud of @saramoufarrij1 who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! @TeamEndo_MSK @TeamOvary_MSK @MSKCancerCenter @MSK_DeptOfMed
0
0
4
RT @MSKLibrary: Featured today by @MSKLibrary: Evolution of tumor stress response during cytoreductive surgery for ovarian cancer https://t….
0
5
0
RT @DFCI_BreastOnc: New @JCO_ASCO paper showcasing a validated, novel post neoadjuvant prognostic #BreastCancer staging system. 🔓https:/….
0
24
0
Super interesting - BRCA2 deep deletions may present a future target for uterine LMS. New study out of @MSKCancerCenter . #gynscm #uterinecancer @JCOPO_ASCO.
Check this new study reporting promising efficacy of PARPis in patients with BRCA-altered uterine sarcoma. @AliSchram @AmirMomeniBr.
1
1
10
Getting #ergonomics coaching and stretching advice at #SGOMtg2025 for the OR and for the office!. Located in room 617. @RyanKahnMD1
0
1
18
RT @YingLiu88: Super star @MariaRubinstein presenting the impressive results of DB1305, a TROP2 targeting ADC, in #ovariancancer @ #SGO2025….
0
7
0
Heading out to #sgomtg 2025 in Seattle! Brought both a raincoat and an umbrella 😅 See you guys there!.
0
0
11
Proud to be a part of this great Disease Management Team! Happy #InternationalWomenDay everyone 💪🦾❤️🔥.
On this #InternationalWomensDay our entire DMT along with @IGCSociety affirms our shared goal to #AccelerateAction through mentorship, education, idea-sharing and advocacy to create a world where all women have access to excellent care. @TeamEndo_MSK @TeamOvary_MSK @aburustummd
0
0
10
RT @JAMAOnc: Quitting smoking within 6 months of a cancer diagnosis improves survival outcomes, with the greatest benefits observed in thos….
0
72
0
⚡️#genetictesting (GT) occurred directly in oncology clinics (mainstreaming).⚡️rates of GT uptake were 91% for #ovariancancer 75% for #endometrialcancer.⚡️reasons for lack of GT included overwhelmed pts or being missed by the team.‼️we can do better! .🧵(2/2)
0
1
3
Check out our new article "Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing" at @JCOPO_ASCO . @YingLiu88 @Moe_ByrneMD @KaraLongRoche @dchimd @StadlerZsofia @aburustummd @MSKCancerCenter . 🧵(1/2).
ascopubs.org
PURPOSEAlthough germline genetic testing (GT) is recommended for all patients with ovarian cancer (OC) and some patients with endometrial cancer (EC), uptake remains low with multiple barriers. Our...
1
7
14
RT @RiosDoriaMD: Excellent highlight of an article by my friend & colleague @tsialater & all at @TeamEndo_MSK . “…with improved geriatric a….
0
5
0
#gynscm community - This is one podcast to listen to this week! Featuring the brilliant @ChrisDagherMD and @aburustummd from @TeamEndo_MSK @MSKCancerCenter.
#WeeklyPodcast LVSI Classification and Impact on Outcomes in Stage I #EndometrialCancer with @ChrisDagherMD and @aburustummd. 🎧 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows
1
2
12